5.710USD-2.56%Mkt Cap: 69.24M USDP/E: —Last update: 2026-06-01
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astig…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap69.24M USD
Enterprise Value73.07M USD
Revenue (TTM)57.70M USD
Gross Profit27.12M USD
Net Income (TTM)-34.28M USD
Revenue/Share4.787 USD
Last Price5.710 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees150
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.17
PEG—
EV/EBITDA-6.17
EV/Revenue1.27
P/S1.22
P/B6.50
EPS (TTM)-0.55
EPS (Forward)-0.71
52W Range
5.0608% of range13.71
52W High13.71 USD
52W Low5.060 USD
Profitability
Gross Margin46.41%
Oper. Margin49.24%
EBITDA Margin-20.52%
Profit Margin-58.66%
ROE131.75%
ROA-47.99%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.83M USD
CapEx (TTM)83.00K USD
FCF Margin-29.81%
FCF Yield-24.84%
Net Debt-10.92M USD
Net Debt/EBITDA0.92
Balance Sheet
Debt/Equity-0.11
Current Ratio2.38
Quick Ratio1.05
Book Value/Sh0.8920 USD
Cash/Share1.115 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.500 USD
Target Range7.000 USD – 10.00 USD
# Analysts2
Ownership
Shares Out.12.10M
Float8.70M
Insiders21.50%
Institutions52.78%
Short Interest
Short Ratio12.5d
Short % Float10.81%
Short % Out.7.84%
Shares Short949.47K
Short (prev mo.)1.01M
Technical
SMA 505.725 (-0.3%)
SMA 20010.27 (-44.4%)
Beta0.84
S&P 52W Chg27.94%
Avg Vol (30d)61.04K
Avg Vol (10d)48.35K
Technical Indicators
RSI (14)49.6
MACD-0.0218
MACD Signal-0.0959
MACD Hist.+0.0742
BB Upper6.169 USD
BB Middle5.734 USD
BB Lower5.299 USD
BB Width15.17%
ATR (14)0.3037 USD
Vol Ratio (20d)0.37x